Raloxifene
Also known as: Evista, raloxifene hydrochloride
Classification
Serm
Regulatory Status
FDA-approved prescription product or labeled drug class
Mechanism Summary
Raloxifene is represented by its commonly described selective estrogen receptor modulator mechanism. This conservative launch record supports search and overlap detection, not medical recommendation.
Reported cautions in source data
tamoxifen duplication
These are observational flags for review, not individualized instructions.
Pathways
estrogen-receptor-modulationbone-densityselective estrogen receptor modulatorbone-density-support
Benefits
Evidence reviewed for osteoporosis treatment/prevention or breast cancer risk reduction per label; BioStack presents this as educational reference, not a recommendation.
Drug Interactions
cholestyramine — Potential additive or opposing effects may occur. (review)
References
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Raloxifene
Educational reference only — not medical advice.